<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26505" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pacemaker Insertion</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Puette</surname>
            <given-names>Jeffrey A.</given-names>
          </name>
          <aff>West Virginia University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malek</surname>
            <given-names>Ryan</given-names>
          </name>
          <aff>Mclaren Macomb</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Intisar</given-names>
          </name>
          <aff>Aga Khan University Pakistan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ellison</surname>
            <given-names>Matthew B.</given-names>
          </name>
          <aff>WVU Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jeffrey Puette declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ryan Malek declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Intisar Ahmed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Ellison declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26505.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pacemakers are medical devices designed to regulate abnormal heart rhythms by delivering electrical pulses to the heart. They are used primarily to treat bradycardia due to sinus node dysfunction or atrioventricular block, among other cardiac conditions. Pacemakers can be temporary or permanent, depending on the patient&#x02019;s needs, and advancements in technology since the 1950s have greatly improved their functionality. Modern pacemakers, along with implantable cardioverter-defibrillators, form a category of cardiac implantable electronic devices. While the implantation procedure is generally safe, risks such as infection, lead dislodgement, and battery depletion must be carefully managed.</p>
        <p>In this course, participants gain a deeper understanding of pacemaker indications, coding systems, and proper device management. By familiarizing themselves with the pacemaker code, especially the lesser-known fourth and fifth positions, healthcare professionals enhance their ability to optimize device settings. Collaboration within an interprofessional team, including cardiologists, electrophysiologists, and nurses, ensures a comprehensive approach to patient care. This teamwork leads to more accurate device programming, effective monitoring, and improved clinical outcomes for patients with heart rhythm disorders.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the appropriate indications for pacemaker implantation in patients with bradycardia and other cardiac rhythm disorders.</p></list-item><list-item><p>Differentiate between temporary and permanent pacemakers based on patient needs and clinical presentations.</p></list-item><list-item><p>Screen patients for potential complications related to pacemaker implantation, such as infection or lead dislodgement.</p></list-item><list-item><p>Apply interprofessional team strategies and communication efforts to improve care coordination and outcomes&#x000a0;for patients with pacemakers.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26505&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26505">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26505.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pacemakers are adjustable artificial electrical pulse generators, frequently emitting a pulse with a duration between 0.5 and 25 ms with an output of 0.1 to 15 V at a frequency of up to 300/min. The cardiologist or pacemaker technologist will be able to&#x000a0;interrogate and control the pacing rate, the pulse width, and the voltage, whether the device is temporary or permanent.<xref ref-type="bibr" rid="article-26505.r1">[1]</xref> Pacemakers are typically categorized as temporary and permanent. Temporarily, pacemakers are almost always placed to stabilize the patient temporarily or facilitate some surgical procedure.<xref ref-type="bibr" rid="article-26505.r2">[2]</xref>&#x000a0;The implantable pacemakers are usually permanent and often significantly more complex than temporary pacemakers.<xref ref-type="bibr" rid="article-26505.r3">[3]</xref></p>
        <p>The true beginning of the&#x000a0;concept of a pacemaker&#x000a0;began over 200 years ago. In the late 1700s, Luigi Galvani discovered that he could cause the contraction of a frog's heart simply&#x000a0;by passing an electrical current through the heart.&#x000a0;This concept was further realized nearly 100 years later with the first successful resuscitation of a child by Guilliame de Boulogne using electricity. He accomplished this by introducing an electrical current to the patient's chest with a return electrode on the leg after a drowning. After this feat, many successful resuscitations were reported, leading to Dr. Hyman's term "artificial cardiac pacemaker" in 1932.<xref ref-type="bibr" rid="article-26505.r4">[4]</xref><xref ref-type="bibr" rid="article-26505.r5">[5]</xref></p>
        <p>Pacemakers are one cardiac implantable electronic device type (CIED). This broad category also includes implantable cardioverter-defibrillators (ICDs). This group of devices was introduced in the 1950s, shortly after the advent of&#x000a0;the transistor. As technology has improved, so has the pacemaker device. The first implantable ICD was developed in 1980. Since then, it has become more challenging to differentiate between pacemakers and ICDs because every ICD currently&#x000a0;implanted has an antibradycardia pacing function.<xref ref-type="bibr" rid="article-26505.r6">[6]</xref>&#x000a0;The patient and any clinician should understand which device has been implanted to prevent unnecessary ICD therapy, which is most likely to occur with any electromagnetic interference and could lead to device activation with an ICD. Most types of CIED use several insulated lead wires with non-insulated tips that are implanted in the heart, either by percutaneous vein insertion or directly by a cardiac surgeon. Cardiac pacemakers comprise the pulse generator and the leads or electrodes.<xref ref-type="bibr" rid="article-26505.r1">[1]</xref></p>
        <p>The North American Society of Pacing and Electrophysiology and the British Pacing and Electrophysiology Group jointly developed a generic pacemaker code utilized worldwide that would allow clinicians and manufacturers to describe the device's characteristics, which was last updated in 2002 (see <bold>Image</bold>.&#x000a0;Pacemaker Table).<xref ref-type="bibr" rid="article-26505.r7">[7]</xref>&#x000a0;The first letter in the code indicates which chamber is paced; the second letter indicates which chamber is being sensed by the device; the third letter indicates if there is a response to sensing; the fourth position indicates whether the device will modulate or change&#x000a0;the programmed rate independent of the patient's cardiac activity, for example, with exercise; the fifth and last letter of the code indicates additional multisite pacing.&#x000a0;The last 2 letters of the code (in the fourth and fifth position) are rarely used in typical nomenclature.<xref ref-type="bibr" rid="article-26505.r7">[7]</xref>&#x000a0;The latest generation of pacemakers has many capabilities.<xref ref-type="bibr" rid="article-26505.r8">[8]</xref>&#x000a0;The simplest settings are AAI and VVI. The AAI mode paces and senses in the atrium, and each sensed event triggers the generator to fire within the P wave. The VVI mode paces and senses the ventricle and is suppressed by a sensed ventricular event.</p>
      </sec>
      <sec id="article-26505.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>
<bold>Anatomy and Physiology of Cardiac Conduction System</bold>
</p>
        <p>The cardiac conduction system is a specialized group of cardiac muscle cells responsible for generating and transmitting electrical impulses that coordinate heart muscle contraction. The following are the primary anatomic components of the cardiac conduction system:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Sinoatrial node</bold>:&#x000a0;The sinoatrial (SA) node is the dominant pacemaker of the heart that generates the electrical impulse that travels through the atria and depolarizes the ventricles via the specialized Purkinje fibers. The SA node is an elongated, spindle-shaped structure composed of specialized cells packed in the fibrous tissue matrix and is located close to the epicardial surface of the right atrium, at the junction of the superior vena cava and the right atrium.<xref ref-type="bibr" rid="article-26505.r9">[9]</xref>&#x000a0;This is supplied by the SA nodal branches of the right coronary artery (55% to 60%) or the left circumference artery (35% to 40%). The SA node rarely gets blood supply from the right coronary and left circumference arteries.<xref ref-type="bibr" rid="article-26505.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Atrioventricular node</bold>: The atrioventricular node connects the atrial to the ventricles and transmits impulses from the atria to the ventricles. The compact atrioventricular node is a superficial structure located subendocardial, in the interatrial septum, at the apex of the triangle of Koch, a triangle formed by the tricuspid annulus anteriorly and the tendon of Todaro posteriorly. Branches of the right coronary artery supply the atrioventricular node in 80% to 90% of the patients. In comparison, in 10% to 20% of the people, it is supplied by the branches of the left circumference artery.<xref ref-type="bibr" rid="article-26505.r11">[11]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Bundle of His</bold>:&#x000a0;The bundle of His is a thin structure with specialized conduction cells connecting the distal part of the compact atrioventricular node to the distal conduction system. This structure perforates the central fibrous body and continues through the annulus fibrosus into the interventricular septum, dividing into bundle branches. As the proximal part of the His bundle is a continuation of the atrioventricular node, the cells of the penetrating His bundle resemble those of the compact atrioventricular node, while the distal His bundle structures are identical to the proximal bundle branches.<xref ref-type="bibr" rid="article-26505.r12">[12]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Bundle branches and Purkinje fibers</bold>:<bold>&#x000a0;</bold>The bundle branches originate at the superior margin of the muscular interventricular septum, immediately below the membranous septum. The right bundle branch continues into the interventricular septum as an extension of His bundle to the apex of the right ventricle and base of the anterior papillary muscle. The anatomy of the left bundle branch is variable; it divides into the anterior and posterior fascicles and gives a septal fascicle in some individuals.<xref ref-type="bibr" rid="article-26505.r13">[13]</xref>&#x000a0;The bundle branches divide into the Purkinje fibers, a network of fast-conducting fibers at the endocardial surface of the myocardium. These fibers transmit electrical impulses almost simultaneously to both ventricles, resulting in synchronized contraction.<xref ref-type="bibr" rid="article-26505.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26505.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Indications of Permanent Pacemakers</bold>
</p>
        <p>Permanent pacemakers are indicated for individuals who have bradycardia due to sinus node dysfunction or atrioventricular block. Contemporary guidelines recommend pacemakers in the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Symptomatic sinus node dysfunction</bold>: A permanent pacemaker is indicated in patients with sinus node dysfunction (eg, symptomatic sinus bradycardia, chronotropic incompetence, symptomatic sinus pauses, or tachycardia-bradycardia syndrome).</p>
          </list-item>
          <list-item>
            <p><bold>Atrioventricular block</bold>: If a reversible cause of atrioventricular block is not identified in patients with Mobitz II atrioventricular block, advanced atrioventricular block, or complete atrioventricular block, a permanent pacemaker is indicated irrespective of symptoms.</p>
          </list-item>
          <list-item>
            <p><bold>Atrioventricular conduction disease in the presence of neuromuscular disorders</bold>: A permanent pacemaker is indicated irrespective of symptoms in patients with neuromuscular disorders who have second-degree atrioventricular block, high-grade or third-degree atrioventricular block or distal conduction system disease with an HV interval of &#x0003e;70 ms.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Permanent atrial fibrillation with bradycardia</bold>: A permanent pacemaker is indicated in patients with atrial fibrillation with a slow ventricular rate, irrespective of bradycardia-related symptoms.</p>
          </list-item>
          <list-item>
            <p>&#x000a0;<bold>Bradycardia due to guidelines-directed medical therapy</bold>:&#x000a0;A permanent pacemaker is indicated in patients who develop guidelines-directed medical therapy-induced bradycardia, and no alternative medical treatment is available.</p>
          </list-item>
          <list-item>
            <p><bold>Symptomatic first-degree or atrioventricular Wenckebach</bold>: A permanent pacemaker can be considered in symptomatic patients with gross first-degree atrioventricular block (PR &#x0003e;300 ms) or atrioventricular Wenckebach.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Distal conduction disease with syncope</bold>: A permanent pacemaker may also be considered in patients with bifascicular block who present with cardiac syncope, and no other causes of syncope are identified.<xref ref-type="bibr" rid="article-26505.r15">[15]</xref><xref ref-type="bibr" rid="article-26505.r16">[16]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26505.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Though no absolute contraindications to the pacemaker implantation have been established, a transvenous permanent pacemaker is not recommended in the presence of an active infection, especially bacteremia. The other contraindications may include patient refusal and terminal illness where a pacemaker is not expected to improve quality of life. In patients whose vascular and cardiac anatomy is not favorable for a conventional transvenous pacemaker, an epicardial lead placement with thoracoscopy/thoracotomy should be considered an alternative option.<xref ref-type="bibr" rid="article-26505.r17">[17]</xref></p>
      </sec>
      <sec id="article-26505.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Implanting a pacemaker is a specialized procedure that requires specific equipment to ensure accuracy, safety, and efficacy. The following equipment and tools are the primary implements necessary for a pacemaker implantation procedure:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Pacemaker pulse generator</bold>: This device contains the pacemaker's battery and electronic circuitry; it generates electrical impulses that are delivered to the heart via the leads.</p>
          </list-item>
          <list-item>
            <p><bold>Pacemaker leads</bold>: These are insulated wires that carry electrical impulses from the pacemaker generator to the heart muscle. Depending on the type of pacing needed, different types of leads are available, including atrial and ventricular leads.</p>
          </list-item>
          <list-item>
            <p>
<bold>Implantation tools</bold>
</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Scalpel and dissection instruments</bold>: These are used to create the incision, dissect tissues to access the implantation site, and create a pocket.</p>
              </list-item>
              <list-item>
                <p><bold>Forceps and scissors</bold>: These instruments are used for handling tissues and cutting sutures.</p>
              </list-item>
              <list-item>
                <p><bold>Needles and sutures</bold>: These are used to suture the leads and incision site after implantation.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Fluoroscopy equipment</bold>: This equipment provides real-time x-ray images of the heart and the positioning of leads during the procedure, ensuring accurate placement.</p>
          </list-item>
          <list-item>
            <p><bold>Electrocautery</bold>: This is used to control bleeding during the surgery by coagulating tissue and blood vessels.</p>
          </list-item>
          <list-item>
            <p><bold>Sterile drapes and surgical gowns and gloves</bold>: Maintain a sterile field to reduce the risk of infection during the procedure.</p>
          </list-item>
          <list-item>
            <p><bold>Cardiac monitoring equipment</bold>: Provides continuous monitoring of the patient's heart rhythm and vital signs throughout the procedure.</p>
          </list-item>
          <list-item>
            <p><bold>Anesthesia equipment</bold>: Includes medications and equipment for administering anesthesia to the patient during the implantation.</p>
          </list-item>
          <list-item>
            <p><bold>X-ray machine</bold>: Used in combination with fluoroscopy to visualize the heart and guide the placement of the leads.</p>
          </list-item>
          <list-item>
            <p><bold>Temporary pacemaker</bold>: May be considered in case of complications or if temporary pacing is needed during or after the procedure.</p>
          </list-item>
          <list-item>
            <p><bold>Electrocardiogram machine</bold>: Used for monitoring the patient's heart rhythm and ensuring proper function of the pacemaker postimplantation.</p>
          </list-item>
          <list-item>
            <p><bold>Surgical lights</bold>: Provide adequate illumination of the surgical field during the procedure.</p>
          </list-item>
          <list-item>
            <p><bold>Postoperative monitoring equipment</bold>: Includes equipment for monitoring the patient's recovery in the immediate postoperative period.</p>
          </list-item>
        </list>
        <p>The operating room should also be equipped with standard surgical instruments and supplies, including sterile gauze, sponges, and irrigation solutions.&#x000a0;Pacemaker implantation is typically performed in a specialized cardiac catheterization laboratory or an operating room equipped with all necessary monitoring and imaging capabilities to ensure the procedure's success and the patient's safety.</p>
      </sec>
      <sec id="article-26505.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Pacemaker implantation is performed by a specialized cardiologist (ie, cardiac electrophysiologist) or a cardiac surgeon. The procedure requires a team with extensive training and experience in caring for these complex patients. Other team members may include an electrophysiology fellow, an electrophysiology nurse, a technician, an anesthesiologist or anesthesia assistant, and a radiographer.</p>
      </sec>
      <sec id="article-26505.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>The first step of preparation is to evaluate the indication of pacing and perform a risk-benefit analysis by taking a detailed history and doing a clinical examination of the patient. The patient should be free of infection for at least 24 hours before implant, and prophylactic antibiotics should be administered in all cases (eg, cephazolin 1 to 2 g or flucloxacillin 1 to 2 g within 1 hour of incision, or, in case of allergy, vancomycin 15 mg/kg within 90 to 120 min).<xref ref-type="bibr" rid="article-26505.r18">[18]</xref>&#x000a0;Patients on anticoagulation require special consideration as they are at higher risk of pocket hematoma, which increases the risk of infection. Interruption of anticoagulation can be considered in patients with non-valvular atrial fibrillation with relatively low stroke risk, while those with mechanical valves and high stroke risk can have device implants without interruption of anticoagulation, provided the International Normalized Ratio is less than 3.5.</p>
        <p>The BRUISE-CONTROL 2 study results show no difference in hematoma in patients undergoing pacemaker implants with or without interruption of direct oral anticoagulants.<xref ref-type="bibr" rid="article-26505.r19">[19]</xref>&#x000a0;However, interruption of anticoagulation should be individualized based on patient characteristics and bleeding and ischemic risk. Before starting the procedure, operators should ensure all required equipment is available. Preoperative safety checks and surgical time-outs are encouraged to avoid errors. Anesthesia support should be available for potentially life-threatening complications, as well as to assist with sedation and hemodynamic support if required.</p>
      </sec>
      <sec id="article-26505.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Pocket Creation</bold>
</p>
        <p>Left-sided implants are preferred, as they are the nondominant side for most patients, and lead placement is relatively more straightforward.&#x000a0;However, the decision should be individualized according to the specific requirements. After infiltration of local anesthetic (1% lidocaine or lidocaine mixed with bupivacaine), a horizontal (below the clavicle) or an oblique incision (parallel to the deltopectoral groove) is made.<xref ref-type="bibr" rid="article-26505.r20">[20]</xref>&#x000a0;The oblique incision provides better access for cephalic cutdown; however, the pocket should be created medially to minimize the migration of the device into the axilla. Dissection is carried down to the pre-pectoral fascia, creating a subcutaneous pocket. A subpectoral pocket is considered in lean individuals who do not have much subcutaneous fat to minimize pocket erosion.<xref ref-type="bibr" rid="article-26505.r21">[21]</xref>&#x000a0;Submuscular pockets can also be considered for cosmetic purposes and, in rare cases, to minimize the risk of Toddler syndrome in special populations.</p>
        <p>
<bold>Vascular Access</bold>
</p>
        <p>Vascular access is performed by axillary or subclavian puncture under fluoroscopy or by cephalic cutdown under direct vision. The intrathoracic subclavian vein has a higher risk of pneumothorax, so the extrathoracic subclavian or axillary vein is the preferred puncture site in the contemporary era.<xref ref-type="bibr" rid="article-26505.r22">[22]</xref>&#x000a0;Axillary vein puncture can be easily performed using fluoroscopic landmarks. The caudal tilt of 35 degrees helps expose the outer margin of the lung, allowing safe puncture and minimizing the risk of pneumothorax by targeting the outer margin of the first rib.<xref ref-type="bibr" rid="article-26505.r23">[23]</xref>&#x000a0;A venogram can be used to guide the puncture when the vein is not accessible under fluoroscopy. Cephalic cutdown avoids the risk of pneumothorax and has lower chances of lead dysfunction than subclavian access.<xref ref-type="bibr" rid="article-26505.r24">[24]</xref>&#x000a0;Though cephalic cutdown has a relatively higher risk of bleeding, it is not significantly different from the conventional subclavian access.<xref ref-type="bibr" rid="article-26505.r24">[24]</xref></p>
        <p>
<bold>Implantation of Pacing Leads</bold>
</p>
        <p>The active or passive fixation leads are implanted according to the operator's preferences; however, the active fixation leads have a lower risk of lead dislodgements than passive fixation leads. Leads are stylet-driven, and atrial leads usually come with preformed, U-shaped stylet. The right ventricular lead is usually implanted first to provide backup pacing if required and to avoid atrial lead dislodgement during ventricular lead placement. Common sites for ventricular lead implantation include the right ventricular apex and interventricular septum, while the septal right ventricular outflow tract is rarely used.<xref ref-type="bibr" rid="article-26505.r25">[25]</xref>&#x000a0;</p>
        <p>Traditionally, the right ventricular apex had been the common site for right ventricular lead placement due to technical feasibility and the stable position of passive leads due to trabeculae. However, a higher risk of perforation associated with the apical position has made the interventricular septum the preferred implant site for active fixation of the right ventricular lead.<xref ref-type="bibr" rid="article-26505.r26">[26]</xref>&#x000a0;The tricuspid valve is crossed by modifying the straight stylet and making a curve at its distal end. A clockwise torque is used to avoid inadvertent cannulation of the coronary sinus. Ventricular ectopy and the left anterior oblique (LAO) projection can confirm the lead position in the right ventricular lead.</p>
        <p>The same manual stylet or a different stylet curve is used to place the lead at the desired site in the right ventricle. Two orthogonal fluoroscopic projections are recommended to confirm the right ventricular lead and avoid the lead placement into the free wall of the right ventricle. Once the lead is at a desired position, the screw of the active fixation lead is deployed, and fluoroscopic markers are used to confirm the deployment. Over-rotation of the helix should be avoided as it may lead to lead dislodgement.<xref ref-type="bibr" rid="article-26505.r3">[3]</xref></p>
        <p>After deployment, checking for the current of injury and testing the lead for sensed R wave amplitude and pacing threshold is recommended. The atrial lead is usually placed with a preformed U-shaped stylet, facilitating lead position into the right atrial appendage. However, a slight modification of the stylet or even lead placement at the alternate sites is required in select groups of patients when satisfactory pacing and sensing parameters or the desired position is not achieved with the conventional U-shaped stylet. After atrial lead deployment, stability should be tested by pulling the stylet back into the superior vena cava and pushing the lead toward the tricuspid valve. Both the leads should be tested for current of injury, sensed amplitude, and pacing threshold after deployment.&#x000a0;</p>
        <p>After placement and achieving the satisfactory<bold>&#x000a0;</bold>parameters, leads are secured by suturing with the pectoralis muscle. Usually, the non-absorbable sutures are tied over the muscle and then over the suturing sleeves.<xref ref-type="bibr" rid="article-26505.r27">[27]</xref>&#x000a0;The leads are connected to the atrial and ventricular ports of the pulse generator and placed in the preformed pocket. The lead switch in the pulse generator header is an infrequent complication when atrial and ventricular leads are switched in the pulse generator and connected to the wrong port. Ideally, the serial numbers of the leads should be checked before being connected to the pulse generator to avoid the lead switch in the header.<xref ref-type="bibr" rid="article-26505.r28">[28]</xref></p>
        <p>
<bold>Pocket Closure</bold>
</p>
        <p>The pocket should be examined for bleeding before closure. Saline wash can be considered to clean the pocket before placing the pacemaker and leads. The pacemaker should be placed in the pocket in a way that the header is placed toward the incision to make device removal easier during pulse generator replacement. The leads should be placed under the device to minimize the chances of Toddler syndrome and minimize the damage to the leads during re-exploration and pulse generator replacement. Although pocket closure techniques vary, the closure is usually done in 2 to 3 layers. The subcutaneous tissue is commonly closed in 2 layers of 2-0 or 3-0 resorbable suture, and the subcuticular tissue and skin are closed with a braided resorbable, 4-0 suture.&#x000a0;</p>
        <p>
<bold>Postoperative Care</bold>
</p>
        <p>Postoperative care after pacemaker implantation is crucial to ensure proper healing, prevent complications, and optimize the function of the pacemaker system.</p>
        <p>
<bold>Immediate postoperative period</bold>
</p>
        <p>In the immediate postoperative period following pacemaker implantation, careful monitoring is essential, including regular checks of vital signs such as heart rate, blood pressure, and oxygen saturation, along with continuous monitoring of the pacemaker function and heart rhythm to ensure proper pacing and sensing. Wound care is crucial, with the surgical incision site needing to be kept clean and dry and closely observed for signs of infection like redness, swelling, warmth, or drainage. While there are no specific limitations on general activity, patients should avoid strenuous activity or heavy lifting with the arm on the side of the pacemaker to prevent dislodging the leads, though the chance of this happening is minimal. Pain management instructions provided by clinicians should be tailored to the patient's comfort.</p>
        <p>
<bold>Discharge and long-term care</bold>
</p>
        <p>Education becomes a key component as patients transition to discharge and long-term care. Patients and their caregivers should be informed about the pacemaker's function, including recognizing normal versus abnormal symptoms, and advised on activity restrictions (eg, avoiding strong electromagnetic fields or engaging in vigorous contact sports). Clear instructions should be provided regarding follow-up care, including scheduled visits with a cardiologist or electrophysiologist. Patients must also understand any prescribed medications, such as antibiotics or pain management drugs, and be aware of any driving restrictions based on local regulations and their medical condition. For some, remote monitoring of the pacemaker may be available, allowing device function to be checked and issues detected early without frequent clinic visits. Encouraging a healthy lifestyle, including regular exercise as their clinician advises, a balanced diet, and smoking cessation, is also vital. Patients should be informed about when to seek emergency medical attention, such as in cases of chest pain, palpitations, dizziness, or fainting.</p>
        <p>
<bold>Follow-up visits</bold>
</p>
        <p>Follow-up visits are critical for ensuring ongoing pacemaker function. During these visits, the device's performance will be evaluated, and adjustments may be made to optimize settings. The pacemaker's battery life will also be monitored to plan for future generator replacements. Continuous education and support for the patient and caregivers about ongoing care, lifestyle modifications, and any changes in pacemaker management are essential for long-term success. The interprofessional healthcare team can help patients recover smoothly from pacemaker implantation through comprehensive postoperative care and achieve optimal long-term outcomes in managing their cardiac health.</p>
      </sec>
      <sec id="article-26505.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Pacemaker implantation is generally a safe procedure with a high success rate, but like any surgical intervention, it carries some potential risks and complications. These complications can range from minor to more severe issues. Common complications associated with pacemaker implantation include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Arrhythmia</bold>: Nonsustained ventricular arrhythmia is commonly observed during ventricular lead placement, especially the manipulation of lead through the tricuspid valve into the right ventricular outflow tract. Sustained ventricular arrhythmia and atrial tachyarrhythmia are rarely noted during pacemaker implantation.</p>
          </list-item>
          <list-item>
            <p><bold>Infection</bold>: Infection can occur at the surgical site or along the pathway of the leads into the heart. This can lead to localized swelling, redness, pain, and fever. The pacemaker system may be removed in severe cases, and antibiotic treatment may be required. The overall incidence of pacemakers and cardiac implantable electronic devices ranges from 0.6% to 3.4%.<xref ref-type="bibr" rid="article-26505.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Bleeding and pocket hematoma</bold>: Bleeding can occur during or after the procedure, either at the incision site or internally. Most cases are minor, but significant bleeding leading to pocket hematoma may require re-exploration of the pocket. The incidence of pocket hematoma varies&#x000a0;widely, from &#x0003c;0.5% to as high as 16%.<xref ref-type="bibr" rid="article-26505.r3">[3]</xref>&#x000a0;Pocket&#x000a0;hematoma increases the risk of pacemaker infection.</p>
          </list-item>
          <list-item>
            <p><bold>Lead-related complications</bold>:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p><bold>Lead dislodgement</bold>: Leads can move from their intended position, causing improper pacing or failure to sense the heart's electrical activity correctly.</p>
              </list-item>
              <list-item>
                <p><bold>Lead fracture</bold>: Leads can break or fracture, which may lead to malfunction of the pacemaker system.</p>
              </list-item>
              <list-item>
                <p><bold>Venous thrombosis</bold>: Blood clots forming in the vein where the leads are placed can impede blood flow.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Pneumothorax</bold>: A puncture of the lung tissue during the insertion of leads, leading to the accumulation of air in the chest cavity. This may require drainage.</p>
          </list-item>
          <list-item>
            <p><bold>Cardiac perforation</bold>: Rarely, the leads can puncture the heart chambers or other structures within the chest cavity. The true incidence of lead perforation can not be estimated due to the variable definitions; the reported range of perforation varies from &#x0003c;0.1% to as high as 1.5%. Lead perforation is usually reported in the first 4 weeks of implant, rarely occurs in the later period, and is even reported years after the implant.<xref ref-type="bibr" rid="article-26505.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Allergic reaction</bold>: Rarely, patients may be allergic to materials used in the pacemaker system, such as metal alloys or medications.</p>
          </list-item>
          <list-item>
            <p>
<bold>Device-related complications</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p><bold>Battery depletion</bold>: The pacemaker battery has a limited lifespan (usually up to 10 years), after which it needs to be replaced.</p>
              </list-item>
              <list-item>
                <p><bold>Device malfunction</bold>: Rarely, the pacemaker may malfunction, requiring replacement or reprogramming.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Psychological impact</bold>: Some patients may experience anxiety, depression, or adjustment issues related to having a pacemaker implanted.</p>
          </list-item>
          <list-item>
            <p><bold>Long-term complications</bold>: Over time, there is a small risk of complications such as lead insulation breakage, lead calcification, or infection of the device pocket.</p>
          </list-item>
        </list>
        <p>The overall risk of complications is relatively low, and many patients experience significant improvement in their quality of life with a properly functioning pacemaker. Clinicians carefully assess each patient's risk factors and monitor them closely before, during, and after the procedure to minimize the likelihood of complications.</p>
      </sec>
      <sec id="article-26505.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Pacemakers are of significant clinical importance in cardiology due to their ability to treat and manage various cardiac rhythm disorders. The clinical significance of pacemakers includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>Bradycardia treatment</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Pacemakers are primarily used to treat bradycardia, which can lead to symptoms such as dizziness, fainting, fatigue, and shortness of breath. Pacemakers help maintain a normal heart rate and improve bradycardia-related symptoms.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Heart block management</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Heart block is a condition in which the electrical signals from the atria to the ventricles are delayed or blocked.</p>
              </list-item>
              <list-item>
                <p>Pacemakers can effectively bypass these blockages by delivering electrical impulses directly to the ventricles or maintaining appropriate timing between atrial and ventricular contractions.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Improvement in quality of life</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Pacemakers can significantly improve the quality of life for patients with symptomatic bradycardia or heart block by reducing symptoms such as fatigue, fainting episodes, and shortness of breath.</p>
              </list-item>
              <list-item>
                <p>They enable patients to engage in normal daily activities and exercise without limitations imposed by their heart rhythm disorder.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Syncope and sudden cardiac arrest prevention</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Pacemakers help prevent dangerous complications associated with severe bradycardia, such as syncope (fainting) or even sudden cardiac arrest in some cases.</p>
              </list-item>
              <list-item>
                <p>By maintaining a stable heart rate, pacemakers reduce the risk of life-threatening arrhythmias.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Versatility in management</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Pacemakers can be programmed and adjusted to meet individual patient needs, including variations in heart rate requirements during rest and physical activity.</p>
              </list-item>
              <list-item>
                <p>Advanced pacemaker models may include additional features such as rate response algorithms to increase heart rate during exercise.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Technological advancements</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Continuous advancements in pacemaker technology have improved device longevity, reduced complications, and enhanced monitoring capabilities through remote monitoring systems.</p>
              </list-item>
              <list-item>
                <p>These advancements contribute to better management and outcomes for patients requiring pacemakers.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Indications beyond bradycardia</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Pacemakers may also be used in certain cases of heart failure (eg, cardiac resynchronization therapy) or to manage specific arrhythmias refractory to other treatments.</p>
              </list-item>
              <list-item>
                <p>They play a role in optimizing cardiac function and improving overall heart health in selected patient populations.</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>Overall, pacemakers represent a critical therapeutic intervention for patients with various cardiac rhythm disorders. They offer significant clinical benefits by maintaining appropriate heart rate and rhythm, improving symptoms, and reducing the risk of serious complications associated with bradycardia and heart block.</p>
      </sec>
      <sec id="article-26505.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective postoperative care following pacemaker implantation requires a coordinated, interprofessional approach to enhance patient-centered care, outcomes, safety, and team performance. Advanced clinicians, nurses, pharmacists, and other health professionals must collaborate seamlessly, focusing on vital signs and cardiac rhythm monitoring to ensure proper pacemaker function. Physicians lead in strategizing follow-up care, while nurses handle wound care, patient education, and early detection of complications. Pharmacists contribute to pain management, medication adherence, and educating patients on activity restrictions. Communication among all team members ensures cohesive care, remote monitoring integration, and prompt interventions, fostering patient safety and optimal recovery.</p>
      </sec>
      <sec id="article-26505.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26505&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26505">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/pacemaker/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26505">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26505/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26505">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26505.s14">
        <fig id="article-26505.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pacemaker Table. External pacing is the fastest available method to synchronize cardiac rhythm in all the bradyarrhythmias indicated by the American Heart Association. This temporary method is used to maintain cardiac output in irreversible conditions where a permanent pacemaker is needed or in reversible situations where permanent pacing is contraindicated. Contributed by M Ellison, MD, FASA</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pacemaker_Table" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26505.s15">
        <title>References</title>
        <ref id="article-26505.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulpuru</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Madhavan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2017</year>
            <month>Jan</month>
            <day>17</day>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-210</page-range>
            <pub-id pub-id-type="pmid">28081829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loehry</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Temporary cardiac pacing.</article-title>
            <source>Postgrad Med J</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>76</volume>
            <issue>893</issue>
            <fpage>189</fpage>
            <pub-id pub-id-type="pmid">10928911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Starck</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Auricchio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biffi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Avila</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deharo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Glikson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Israel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Leclercq</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Vernooy</surname>
                <given-names>K</given-names>
              </name>
              <collab>Reviewers:</collab>
              <name>
                <surname>Dagres</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boveda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Butter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marijon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Braunschweig</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mairesse</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Gleva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Defaye</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zanon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lopez-Cabanillas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vassilikos</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Martins Oliveira</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS).</article-title>
            <source>Europace</source>
            <year>2021</year>
            <month>Jul</month>
            <day>18</day>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>983</fpage>
            <page-range>983-1008</page-range>
            <pub-id pub-id-type="pmid">33878762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Crofoot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarwar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weir</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <chapter-title>External Pacemaker</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>9</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">30137851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ivanchina</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Kopylov</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Volkova</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Samojlenko</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Syrkin</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>[Clinical Value of Algorithms of Minimization of Right Ventricular Pacing in Patients With Sick Sinus Syndrome and History of Atrial Fibrillation].</article-title>
            <source>Kardiologiia</source>
            <year>2018</year>
            <month>Aug</month>
            <issue>8</issue>
            <fpage>58</fpage>
            <page-range>58-63</page-range>
            <pub-id pub-id-type="pmid">30131043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matchett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sears</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Hazelton</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kirian</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nekkanti</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The implantable cardioverter defibrillator: its history, current psychological impact and future.</article-title>
            <source>Expert Rev Med Devices</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-50</page-range>
            <pub-id pub-id-type="pmid">19105779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernstein</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Daubert</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>L&#x000fc;deritz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group.</article-title>
            <source>Pacing Clin Electrophysiol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>260</fpage>
            <page-range>260-4</page-range>
            <pub-id pub-id-type="pmid">11916002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x0015a;wier&#x0017c;y&#x00144;ska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Or&#x00119;ziak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>G&#x00142;&#x000f3;wczy&#x00144;ska</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rossillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grabowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Szumowski</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>Caprioglio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sterli&#x00144;ski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Rate-Responsive Cardiac Pacing: Technological Solutions and Their Applications.</article-title>
            <source>Sensors (Basel)</source>
            <year>2023</year>
            <month>Jan</month>
            <day>27</day>
            <volume>23</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">36772467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Quintana</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Anatomy and pathology of the sinus node.</article-title>
            <source>J Interv Card Electrophysiol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-8</page-range>
            <pub-id pub-id-type="pmid">26319648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nerantzis</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Anninos</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Koutsaftis</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Variation in the blood supply of the sinus node.</article-title>
            <source>Surg Radiol Anat</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>10</issue>
            <fpage>983</fpage>
            <page-range>983-4</page-range>
            <pub-id pub-id-type="pmid">20157710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>The architecture of the sinus node, the atrioventricular conduction axis, and the internodal atrial myocardium.</article-title>
            <source>J Cardiovasc Electrophysiol</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>1233</fpage>
            <page-range>1233-48</page-range>
            <pub-id pub-id-type="pmid">9835269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von Knorre</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>The 125th anniversary of the His bundle discovery.</article-title>
            <source>Herzschrittmacherther Elektrophysiol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>116</fpage>
            <page-range>116-121</page-range>
            <pub-id pub-id-type="pmid">29344737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massing</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>TN</given-names>
              </name>
            </person-group>
            <article-title>Anatomical configuration of the His bundle and bundle branches in the human heart.</article-title>
            <source>Circulation</source>
            <year>1976</year>
            <month>Apr</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>609</fpage>
            <page-range>609-21</page-range>
            <pub-id pub-id-type="pmid">1253382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sedmera</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gourdie</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Why do we have Purkinje fibers deep in our heart?</article-title>
            <source>Physiol Res</source>
            <year>2014</year>
            <volume>63</volume>
            <issue>Suppl 1</issue>
            <fpage>S9</fpage>
            <page-range>S9-18</page-range>
            <pub-id pub-id-type="pmid">24564668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glikson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kronborg</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Michowitz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Auricchio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barbash</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Barrab&#x000e9;s</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Braunschweig</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brignole</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Coats</surname>
                <given-names>AJS</given-names>
              </name>
              <name>
                <surname>Deharo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Diller</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Israel</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Keren</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knops</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Kotecha</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Leclercq</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Merkely</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Starck</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thyl&#x000e9;n</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tolosana</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Leyva</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Linde</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abdelhamid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Arbelo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Asteggiano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bar&#x000f3;n-Esquivias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bauersachs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biffi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Birgersdotter-Green</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bongiorni</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>&#x0010c;elutkien&#x00117;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cikes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Daubert</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Drossart</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Fabritz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fauchier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Avil&#x000e9;s</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Foldager</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gadler</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Vinuesa</surname>
                <given-names>PGG</given-names>
              </name>
              <name>
                <surname>Gorenek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hermann Haugaa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hendriks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katus</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Konradi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koskinas</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Linker</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>L&#x000f8;chen</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lumens</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mascherbauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mullens</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Nagy</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Prescott</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Raatikainen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rakisheva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reichlin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Shlyakhto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sitges</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sousa-Uva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Suwalski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Svendsen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Touyz</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Van Gelder</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Vernooy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Waltenberger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Whinnett</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.</article-title>
            <source>Europace</source>
            <year>2022</year>
            <month>Jan</month>
            <day>04</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-164</page-range>
            <pub-id pub-id-type="pmid">34455427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusumoto</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Edgerton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Goldschlager</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Selzman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varosy</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>2018 ACC/AHA/HRS Guideline on the&#x000a0;Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>20</day>
            <volume>74</volume>
            <issue>7</issue>
            <fpage>932</fpage>
            <page-range>932-987</page-range>
            <pub-id pub-id-type="pmid">30412710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Bichell</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Lamberti</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Shepard</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Seslar</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Surgical approaches to epicardial pacemaker placement: does pocket location affect lead survival?</article-title>
            <source>Pediatr Cardiol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>1016</fpage>
            <page-range>1016-24</page-range>
            <pub-id pub-id-type="pmid">20690018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blomstr&#x000f6;m-Lundqvist</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Traykov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bongiorni</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deharo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Saghy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Snygg-Martin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Starck</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tascini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strathmore</surname>
                <given-names>N</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).</article-title>
            <source>Europace</source>
            <year>2020</year>
            <month>Apr</month>
            <day>01</day>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>515</fpage>
            <page-range>515-549</page-range>
            <pub-id pub-id-type="pmid">31702000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birnie</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Healey</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Ayala-Paredes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Coutu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sumner</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Philippon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kalfon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Eikelboom</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Nery</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Lellouche</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sapp</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Essebag</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).</article-title>
            <source>Eur Heart J</source>
            <year>2018</year>
            <month>Nov</month>
            <day>21</day>
            <volume>39</volume>
            <issue>44</issue>
            <fpage>3973</fpage>
            <page-range>3973-3979</page-range>
            <pub-id pub-id-type="pmid">30462279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lokhandwala</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Panicker</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Vora</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A pilot study comparing two sites for incision during pacemaker implantation and their influence on the scar.</article-title>
            <source>Indian Heart J</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>704</fpage>
            <page-range>704-708</page-range>
            <pub-id pub-id-type="pmid">30392510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vandenberk</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rizkallah</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Risk Mitigation of Pacemaker Pocket Erosion in Thin Patients.</article-title>
            <source>CJC Open</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>585</fpage>
            <page-range>585-587</page-range>
            <pub-id pub-id-type="pmid">35734518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XL</given-names>
              </name>
            </person-group>
            <article-title>Optimized Axillary Vein Technique versus Subclavian Vein Technique in Cardiovascular Implantable Electronic Device Implantation: A Randomized Controlled Study.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2016</year>
            <month>Nov</month>
            <day>20</day>
            <volume>129</volume>
            <issue>22</issue>
            <fpage>2647</fpage>
            <page-range>2647-2651</page-range>
            <pub-id pub-id-type="pmid">27823994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kulbak</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>A new trick to a routine procedure: taking the fear out of the axillary vein stick using the 35&#x000b0; caudal view.</article-title>
            <source>Europace</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>1157</fpage>
            <page-range>1157-60</page-range>
            <pub-id pub-id-type="pmid">25969438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benz</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Vamos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erath</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hohnloser</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis.</article-title>
            <source>Europace</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-129</page-range>
            <pub-id pub-id-type="pmid">30020452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bongiorni</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Proclemer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dobreanu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marinskis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blomstrom-Lundqvist</surname>
                <given-names>C</given-names>
              </name>
              <collab>Scientific Initiative Committee, European Heart Rhythm Association</collab>
            </person-group>
            <article-title>Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey.</article-title>
            <source>Europace</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>1664</fpage>
            <page-range>1664-8</page-range>
            <pub-id pub-id-type="pmid">24170423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cano</surname>
                <given-names>&#x000d3;</given-names>
              </name>
              <name>
                <surname>Andr&#x000e9;s</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Osca</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sancho-Tello</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Olag&#x000fc;e</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Dolz</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.</article-title>
            <source>Europace</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-102</page-range>
            <pub-id pub-id-type="pmid">26847075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rezazadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rizkallah</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of common suturing techniques to secure implantable cardiac electronic device leads: Which strategy best reduces the lead dislodgement risk?</article-title>
            <source>Can J Surg</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>E7</fpage>
            <page-range>E7-</page-range>
            <pub-id pub-id-type="pmid">30694034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26505.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jastrzebski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pacemaker malfunction due to atrial and ventricular leads switched in the header: two faces of the same mistake?</article-title>
            <source>Pacing Clin Electrophysiol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>733</fpage>
            <page-range>733-5</page-range>
            <pub-id pub-id-type="pmid">18507547</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
